AQST - CIK 0001398733
The table below shows Aquestive Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $110.73M | $129.06M | $60.54M | $68.66M | $77.89M | $89.87M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $8.07M | $7.88M | $8.13M | $7.20M | $7.02M | $6.97M |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $130.18M |
| $151.67M |
| $81.72M |
| $89.17M |
| $96.57M |
| $104.01M |
| Property, plant & equipment | $3.84M | $3.92M | $3.86M | $3.80M | $3.85M | $3.92M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $141.13M | $163.56M | $93.70M | $102.23M | $109.96M | $117.61M |
| Accounts payable | $11.89M | $10.87M | $11.95M | $12.28M | $7.57M | $5.70M |
| Total current liabilities | $31.75M | $25.57M | $23.16M | $18.30M | $15.15M | $13.89M |
| Long-term debt | $45.00M | $45.00M | $45.00M | $45.00M | $45.00M | $45.00M |
| Total liabilities | $175.18M | $167.67M | $166.29M | $163.16M | $155.38M | $153.08M |
| Retained earnings | -$455.06M | -$415.14M | -$399.69M | -$386.14M | -$346.16M | -$334.65M |
| Total equity | -$34.05M | -$4.11M | -$72.59M | -$60.93M | -$45.42M | -$35.48M |